Cleared Traditional

K931784 - HGM ILLUMINATING IMAGING ENDOCULAR PROBE

K931784 is an FDA 510(k) clearance for HGM ILLUMINATING IMAGING ENDOCULAR PROBE, manufactured by Hgm, Inc.. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 326-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
326d
Days
Class 2
Risk

K931784 is an FDA 510(k) clearance for the HGM ILLUMINATING IMAGING ENDOCULAR PROBE. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Hgm, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 1, 1994 after a review of 326 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Hgm, Inc. devices

FDA 510(k) Submission Details - K931784

510(k) Number K931784 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 09, 1993
Decision Date March 01, 1994
Days to Decision 326 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
216d slower than avg
Panel avg: 110d · This submission: 326d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 82
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K931784.
VISULINK 900 ARGON
K952894 · Carl Zeiss, Inc. · Aug 1995
KEELER MULTILASE 3000
K942180 · Keeler Instruments, Inc. · Nov 1994
MEGABEAM ENDOCULAR PROBE
K935747 · Ceram Optec, Inc. · Apr 1994
NIDEK MODEL AC-2300
K932836 · Nidek, Inc. · Nov 1993
ND:YAG LASER SYSTEMS (VARIOUS MODELS)
K910805 · Heraeus Lasersonics, Inc. · May 1991
CANDELA DIODE TRABECULOPLASTY LASER DTL
K910612 · Candela Laser Corp. · Mar 1991